AstraZeneca confirmed on Friday, April 30, 2021, delays in the production of your vaccines against covid-19 in Latin America, excluding Brazil, but said it will fulfill its commitment to deliver 150 million doses to the region this 2021.
The pharmaceutical company added in a statement sent to Reuters that lower-than-expected production, limited access to critical supplies and longer periods to comply with internal controls had slowed down the process.
Mexico, which contracted with the British company 77.4 million doses, has already received 2.7 million vaccines from this laboratory from its northern neighbor, in an agreement that also involved Canada, and two million more from India, produced by the Serum Institute.
The Latin American country, which has a population of about 126 million inhabitants, has reached almost 25 million injections of AstraZeneca, the American Pfizer, the Chinese Sinovac Y CanSinoas well as the Russian Sputnik V.
The shortage in the supply of vaccines facing Mexico, attributed to delays by pharmaceutical companies, has been aggravated because the second largest economy in Latin America received far fewer doses of Sputnik V than they had remembered and due to some delays in the arrival of the product from Pfizer.
Delays in the arrival of American and European vaccines to Latin America have pushed countries like Mexico Y Argentina to seek agreements with Russia Y Chinaas well as posing a threat to the region’s fragile economic recovery.
The Argentine government met on Wednesday, April 29 with representatives of AstraZeneca to request production information and the drug delivery schedule, at a time when the country suffers a violent second wave of infections.
– .
